The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Wednesday, November 08, 2017
Mitochon announced that it was notified by the US Patent and Trade Mark Office of allowance on its first patent, US 15/002,531.
read more
Tuesday, November 07, 2017
The FDA expanded the approval of Zelboraf for certain adult patients with Erdheim-Chester Disease, a rare cancer of the blood.
read more
Tuesday, November 07, 2017
OncoResponse has closed the acquisition of Paganini Biopharma, acquiring all of its assets including an anti-epithelial membrane protein 2 (EMP2) ...
read more
Tuesday, November 07, 2017
Novoclem announced its lead inhaled antimicrobial drug candidate, BIOC51, has been designated as a Qualified Infectious Disease Product.
read more
Tuesday, November 07, 2017
Novoclem announced its lead inhaled antimicrobial drug candidate, BIOC51, has been designated as a Qualified Infectious Disease Product.
read more
Friday, November 03, 2017
Symic Bio announced the appointment of Wayne Froland, Ph.D., as Executive Vice President of Technical Operations.
read more
ORIC announced the first subject in a Phase 1a clinical study has been dosed with ORIC-101, a potent small molecule inhibitor of the glucocorticoid ...
read more
ENTEROME announced the successful completion of the first Phase 1 clinical study with its lead candidate EB8018.
read more
Wednesday, October 25, 2017
Alopexx Vaccine announced it has completed a Phase 1 clinical trial with AV0328, a vaccine targeting the broadly expressed microbial antigen, poly-N-...
read more
Wednesday, October 25, 2017
Scientists from TSRI have created a new class of ADCs, using a versatile "double decker" technology that ties antibodies and a drug together to ...
read more
BrainStorm announced that the first patients have been enrolled in the Phase 3 clinical trial of NurOwn for the treatment of ALS.
read more
Regeneron and Sanofi announced positive results from a Phase 2 investigational study of dupilumab in adults with active moderate-to-severe ...
read more
SU2C has awarded 10 Catalyst clinical trial projects in which researchers from more than 30 institutions collaborate across academic and corporate ...
read more
Prometic Life Sciences announced the FDA has accepted its BLA for its plasminogen replacement therapy Ryplazim.
read more
Wednesday, October 11, 2017
Ansun BioPharma announced the FDA has granted Breakthrough Therapy Designation to experimental compound DAS181.
read more